Director/PDMR Share Dealings September 30, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Graham Hetherington was granted on September 27, 2013, under the Shire Sharesave Scheme, an option over 467 ordinary shares at an exercise price of £19.24 per share. This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules. Tony Guthrie Deputy Company Secretary For further information please contact: Investor Relations Eric Rojas email@example.com +1 781 482 0999 Sarah Elton-Farr firstname.lastname@example.org +44 1256 894157 Notes to editors Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas. www.shire.com Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Release www.shire.com END -0- Sep/30/2013 15:15 GMT
SHIRE PLC: Director/PDMR Shareholding
Press spacebar to pause and continue. Press esc to stop.